Stock Price Quote

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private
BSE1651.85-12.3 (-0.74 %)
PREV CLOSE ( ) 1664.15
OPEN PRICE ( ) 1672.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 51011
TODAY'S LOW / HIGH ( )1640.00 1672.00
52 WK LOW / HIGH ( )1303 2029
NSE1654.10-10 (-0.6 %)
PREV CLOSE( ) 1664.10
OPEN PRICE ( ) 1671.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1654.10 (166)
VOLUME 483356
TODAY'S LOW / HIGH( ) 1640.10 1672.20
52 WK LOW / HIGH ( )1385.75 2030
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-12 1976
Management Info
Arun Duggal - Chairman - Managing Director
Registered Office

Address Neelam Centre, ' B 'wing,4th Floor, Hind Cycle Road,Worli,
Mumbai,
Maharashtra-400030

Phone 022- 2482 2222

Email secretarialijftjbpharma.com

Website www.jbpharma.com

Registrars Details
Datamatics Business Solutions Ltd.
Plot No. A 16 & 17,Part B Cross Lane,MIDC, Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

14Jul Draft Letter of Offer
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to..
04Jul Updates on Open Offer
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to..
30Jun Announcement under Regulation 30 (LOD
Public Announcement of open offer for acquisition of Company''s equity s..
25Jun J. B. Chemicals & Pharmaceuticals gets
J. B. Chemicals & Pharmaceuticals has received approval from United..
18Jun JB Chemicals & Pharmaceuticals informs
JB Chemicals & Pharmaceuticals has informed that the Company has pub..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit14986525.4
Gross Profit 1991.7 8771.1
Operating Profit 2445.110526.8
Net Sales 9013.437229.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Blue Jet Healthcare (BSE)
peergroup  1012.00 (4.21%)
M.Cap ( in Cr)17554.70
Jubilant Pharmova (BSE)
peergroup  1234.90 (2.87%)
M.Cap ( in Cr)19669.63
Mercury Laboratories (BSE)
peergroup  888.00 (3.71%)
M.Cap ( in Cr)106.56
Sanjivani Paranteral (BSE)
peergroup  247.40 (11.39%)
M.Cap ( in Cr)303.91
Abbott India (BSE)
peergroup  34148.85 (0.06%)
M.Cap ( in Cr)72563.92

Shareholding Pattern

PROMOTERS 47.84%
MUTUAL FUNDS/UTI 16.26%
NON-INSTITUTION 15.14%
FI/BANKS/INSURANCE 1.77%
FII 0.01%
GOVERNMENT 0%

About JB Chemicals & Pharmaceuticals Ltd.

JB Chemicals & Pharmaceuticals Ltd. was incorporated in the year 1976. Its today's share price is 1651.85. Its current market capitalisation stands at Rs 25792.7 Cr. In the latest quarter, company has reported Gross Sales of Rs. 38633.18 Cr and Total Income of Rs.37603.26 Cr. The company's management includes Akshay Tanna, Prashant Kumar, Gaurav Trehan, Nikhil Chopra, Padmini Khare Kaicker, Sumit Bose, Ashwani Kumar Puri, Arun Duggal, Sandeep Phadnis.

It is listed on the BSE with a BSE Code of 506943 , NSE with an NSE Symbol of JBCHEPHARM and ISIN of INE572A01036. It's Registered office is at Neelam Centre, ' B 'wing,4th Floor, Hind Cycle Road,WorliMumbai-400030, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Damania & Varaiya, Deloitte Haskins & Sells LLP, DNV & Co, JK Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.